LPA and cardiovascular disorder: Whether this difference is clinically or biologically relevant is debatable, but the authors’ main finding was that patients with HeFH and ASCVD endpoints had significantly higher Lp(a) plasma levels than unaffected relatives and that Lp(a) was an independent predictor of cardiovascular disease.15